Supplement neobianacid 45 tablets
Estimated delivery: 2-5 working days
Estimated delivery: 2-5 working days
Information on returns and shipments
Payment methods
Drug for the treatment of gastric acidity
Sodium bicarbonate lfm is indicated as a short-term treatment of gastric hyperacidity.
One tablet contains 500 mg of sodium bicarbonate.
Cellulose powder, microcrystalline cellulose, PEG4000, magnesium stearate.
Adults:The usual dose in adults varies between 500 mg and 5 g per day.
Adolescents (12-18 years):1-2 tablets after meals and at bedtime.
Paediatric population: The medicine Sodium Bicarbonate LFM is contraindicated in children under 12 years of age.
Read the package leaflet carefully before starting treatment.
Particular caution is required when administering sodium bicarbonate in case of:
The tablets contain sodium, therefore this should be taken into account. It should be considered in cases where a particularly low-salt diet is recommended, such as in some cases of congestive heart failure, renal impairment, and hypertension. Sodium bicarbonate should be used with caution in cases of anuria or oliguria, due to the increased risk of sodium retention. Furthermore, caution should be exercised in edematous conditions with sodium retention, such as liver cirrhosis, congestive heart failure, renal insufficiency, toxemia, or pregnancy.
In patients with very low gastric acid levels, the effectiveness of sodium bicarbonate on stomach acidity may be reduced. Furthermore, in these subjects, there is the possibility of increased absorption into plasma, with the potential for adverse systemic effects. In patients with potassium depletion, sodium bicarbonate should be administered with caution, and cardiac and electrolyte parameters should be monitored repeatedly. In patients with gastric and small intestinal inflammation or renal insufficiency, sodium bicarbonate increases the risk of excess blood sodium levels.
Sodium bicarbonate can cause changes in the pH of the stomach and urine, thus altering the absorption and elimination processes of many drugs (see section 4.5). It is advisable to allow at least 2 hours to elapse between taking sodium bicarbonate and other medications.
The following are the adverse reactions of orally administered sodium bicarbonate, organized according to the MedDRA system organ classification. There are insufficient data to establish the frequency of the individual effects listed.
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
No clinical data on exposed pregnancies are available for sodium bicarbonate. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3). Caution should be exercised when prescribing the medicinal product to pregnant women. Furthermore, it should be taken into account that the sodium contained in the medicinal product may worsen the oedematous conditions of pregnancy. Therefore, for the treatment of heartburn, it is advisable to use alternative medications that do not contain sodium. Breastfeeding The use of sodium bicarbonate is considered compatible with breastfeeding. Fertility The impact of the use of sodium bicarbonate l.f.m. on fertility is unknown.
Do not store above 30°C. Store in the original package. Keep the bottle tightly closed to protect from moisture. Sodium bicarbonate decomposes slowly in the presence of moisture.
50 tablets
This product has been on sale since 25/10/2019
In the last 30 days, the product's lowest price was 7,28 €